NCT00216775已完成不适用
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 4
- 主要终点
- rate of sustained viral response
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of low-dose interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in patients with chronic hepatitis C.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of Chronic Hepatitis C. Must be infected with genotype 1b viruses
排除标准
- •Hemoglobin levels<8.5g/dL,
- •Platelet counts<50,000/mm3,
- •Total polymorphonuclear counts<1000/mm3
- •Pregnancy,
- •Renal dysfunction,
结局指标
主要结局
rate of sustained viral response
时间窗: 6 months
次要结局
未报告次要终点
研究者
Hiroyuki Marusawa
Dep Gastroenterol
Kyoto University
研究点 (4)
Loading locations...
相似试验
已完成
不适用
A dose comparing study of peginterferon alfa-2b plus ribavirin in chronic hepatitis type C except genotype 1 and high pretreatment viremia.: A randomized open-label pilot study.JPRN-C000000313Hiroshima liver study group120
撤回
不适用
Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsChronic Hepatitis CNCT00571714University of Nebraska
已完成
2 期
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinHepatitis CNCT01309932Bristol-Myers Squibb165
已完成
4 期
Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected PatientsHepatitis C, ChronicHIV InfectionsNCT00553930Sociedad Andaluza de Enfermedades Infecciosas71
已完成
2 期
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4Liver CirrhosisHepatitis C VirusHIV InfectionNCT01006031Sociedad Andaluza de Enfermedades Infecciosas25